Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Serina Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 13 | 21 | +8 |
| Shares | 109.9K | 205.1K | +95.2K (+86.6%) |
| Value | $1.48M | $1.96M | +$482.7K (+32.6%) |
New holders (9)
Institutions that held Serina Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Warren Averett Asset Management, LLC | 23,485 | $225.0K | 0.00% |
| Geode Capital Management, LLC | 22,747 | $217.9K | 0.00% |
| HighTower Advisors, LLC | 22,482 | $215.0K | 0.00% |
| Millennium Management LLC | 21,672 | $207.6K | 0.00% |
| Strategic Investment Solutions, Inc. | 250 | $405 | 0.00% |
| Bank of America Corp | 31 | $297 | 0.00% |
| Piscataqua Savings Bank | 28 | $268 | 0.00% |
| Pacifica Partners Inc. | 8 | $58 | 0.00% |
| Trust Co of Vermont | 1 | $10 | 0.00% |
Sold out (1)
Institutions that held Serina Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Citigroup Inc | 656 | $8.83K |